3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Liver Neoplasms
2
Prostatic Neoplasms
1
Liver Diseases
1
Liver Abscess
1
Carcinoma
1
Adenoma
1
Interventions
halofantrine
2
Sorafenib
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
tislelizumab
1
sintilimab
1
rubitecan
1
repotrectinib
1
pevonedistat
1
pembrolizumab
1
ozanimod
1
lenvatinib
1
ledipasvir, sofosbuvir drug combination
1
gadolinium ethoxybenzyl DTPA
1
fisogatinib
1
ficlatuzumab
1
camrelizumab
1
belinostat
1
avelumab
1
Trabectedin
1
Shadowing Technique, Histology
1
Ramucirumab
1
Patient Navigation
1
Oxaliplatin
1
Nutritional Status
1
Nivolumab
1
Nadroparin
1
N-monoacetylcystine
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Liver Diseases
×
gadolinium ethoxybenzyl DTPA
×
Clear all
NCT01490203
2018-03-23
LiFE
Seoul National University Hospital
Completed
71 enrolled